NM_198578.4:c.4624C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198578.4(LRRK2):​c.4624C>T​(p.Pro1542Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0315 in 1,612,210 control chromosomes in the GnomAD database, including 1,210 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1542P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.030 ( 145 hom., cov: 32)
Exomes 𝑓: 0.032 ( 1065 hom. )

Consequence

LRRK2
NM_198578.4 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 5.49

Publications

33 publications found
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
LRRK2 Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028391778).
BP6
Variant 12-40314059-C-T is Benign according to our data. Variant chr12-40314059-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 39193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0296 (4497/151954) while in subpopulation NFE AF = 0.035 (2380/67924). AF 95% confidence interval is 0.0339. There are 145 homozygotes in GnomAd4. There are 2447 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4497 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK2NM_198578.4 linkc.4624C>T p.Pro1542Ser missense_variant Exon 32 of 51 ENST00000298910.12 NP_940980.4 Q5S007Q17RV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK2ENST00000298910.12 linkc.4624C>T p.Pro1542Ser missense_variant Exon 32 of 51 1 NM_198578.4 ENSP00000298910.7 Q5S007

Frequencies

GnomAD3 genomes
AF:
0.0296
AC:
4497
AN:
151836
Hom.:
145
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00532
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.0192
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00726
Gnomad FIN
AF:
0.138
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0350
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.0318
AC:
7966
AN:
250762
AF XY:
0.0318
show subpopulations
Gnomad AFR exome
AF:
0.00345
Gnomad AMR exome
AF:
0.0235
Gnomad ASJ exome
AF:
0.0174
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.0324
Gnomad OTH exome
AF:
0.0306
GnomAD4 exome
AF:
0.0317
AC:
46326
AN:
1460256
Hom.:
1065
Cov.:
31
AF XY:
0.0314
AC XY:
22843
AN XY:
726462
show subpopulations
African (AFR)
AF:
0.00356
AC:
119
AN:
33404
American (AMR)
AF:
0.0226
AC:
1007
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.0178
AC:
464
AN:
26074
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39646
South Asian (SAS)
AF:
0.00942
AC:
812
AN:
86222
European-Finnish (FIN)
AF:
0.120
AC:
6377
AN:
53356
Middle Eastern (MID)
AF:
0.00903
AC:
52
AN:
5756
European-Non Finnish (NFE)
AF:
0.0322
AC:
35719
AN:
1110862
Other (OTH)
AF:
0.0294
AC:
1770
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2180
4360
6540
8720
10900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1310
2620
3930
5240
6550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0296
AC:
4497
AN:
151954
Hom.:
145
Cov.:
32
AF XY:
0.0329
AC XY:
2447
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.00531
AC:
220
AN:
41464
American (AMR)
AF:
0.0192
AC:
292
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
68
AN:
3464
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00727
AC:
35
AN:
4816
European-Finnish (FIN)
AF:
0.138
AC:
1453
AN:
10552
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0350
AC:
2380
AN:
67924
Other (OTH)
AF:
0.0175
AC:
37
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
202
403
605
806
1008
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0267
Hom.:
127
Bravo
AF:
0.0188
TwinsUK
AF:
0.0283
AC:
105
ALSPAC
AF:
0.0275
AC:
106
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.0329
AC:
283
ExAC
AF:
0.0300
AC:
3645
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.0298
EpiControl
AF:
0.0264

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal dominant Parkinson disease 8 Benign:3Other:1
Sep 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32677286, 26503572) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 17, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
D
MetaRNN
Benign
0.0028
T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
1.6
L
PhyloP100
5.5
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.23
Sift
Benign
0.16
T
Sift4G
Uncertain
0.0060
D
Polyphen
0.98
D
Vest4
0.49
MPC
0.42
ClinPred
0.028
T
GERP RS
5.8
Varity_R
0.11
gMVP
0.78
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33958906; hg19: chr12-40707861; COSMIC: COSV104599036; API